VAREX IMAGING $VREX Shares Sold by Boston Partners

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Boston Partners trimmed its stake in VAREX IMAGING (NASDAQ:VREX - Free Report) by 96.8% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,253 shares of the company's stock after selling 578,509 shares during the period. Boston Partners' holdings in VAREX IMAGING were worth $223,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently added to or reduced their stakes in the company. Aquatic Capital Management LLC purchased a new stake in VAREX IMAGING in the 4th quarter valued at about $25,000. Point72 Hong Kong Ltd bought a new stake in shares of VAREX IMAGING in the 4th quarter valued at about $48,000. Cerity Partners LLC bought a new stake in shares of VAREX IMAGING in the 4th quarter valued at about $147,000. ProShare Advisors LLC bought a new stake in shares of VAREX IMAGING in the 4th quarter valued at about $159,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of VAREX IMAGING by 58.0% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,279 shares of the company's stock valued at $131,000 after purchasing an additional 4,139 shares in the last quarter.

VAREX IMAGING Stock Up 1.0%

Shares of NASDAQ VREX traded up $0.11 during trading hours on Thursday, hitting $11.34. 346,784 shares of the stock were exchanged, compared to its average volume of 551,686. The company has a quick ratio of 1.82, a current ratio of 3.51 and a debt-to-equity ratio of 0.78. The company has a market cap of $470.61 million, a PE ratio of -3.53 and a beta of 0.68. The firm has a fifty day moving average price of $8.48 and a 200-day moving average price of $9.57. VAREX IMAGING has a 12 month low of $6.76 and a 12 month high of $16.93.

VAREX IMAGING (NASDAQ:VREX - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.04 by $0.14. The firm had revenue of $203.00 million during the quarter, compared to analyst estimates of $190.32 million. VAREX IMAGING had a negative net margin of 16.13% and a positive return on equity of 5.54%. VAREX IMAGING has set its Q4 2025 guidance at 0.100-0.300 EPS. On average, sell-side analysts expect that VAREX IMAGING will post 0.53 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Wall Street Zen lowered shares of VAREX IMAGING from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 9th. B. Riley restated a "buy" rating and issued a $16.00 price target (up previously from $12.00) on shares of VAREX IMAGING in a report on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $19.50.

VAREX IMAGING Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.